The global cardiovascular digital solutions market size is calculated at USD 122.05 billion in 2024, grew to USD 128.41 billion in 2025, and is projected to reach around USD 202.82 billion by 2034. The market is poised to grow at a CAGR of 5.21% between 2024 and 2034. The North America cardiovascular digital solutions market size is predicted to increase from USD 50.04 billion in 2024 and is estimated to grow at the fastest CAGR of 5.34% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cardiovascular Digital Solutions Market
5.1. COVID-19 Landscape: Cardiovascular Digital Solutions Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cardiovascular Digital Solutions Market, By Service Type
8.1. Cardiovascular Digital Solutions Market, by Service Type, 2024-2034
8.1.1. Unobtrusive Testing
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. CVD Health Informatics
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cardiac Rehab Programs
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Cardiovascular Digital Solutions Market, By Components
9.1. Cardiovascular Digital Solutions Market, by Components, 2024-2034
9.1.1. Devices
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Software
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Cardiovascular Digital Solutions Market, By Deployment
10.1. Cardiovascular Digital Solutions Market, by Deployment, 2024-2034
10.1.1. Cloud-Based
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. On-premises
10.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Cardiovascular Digital Solutions Market, By End-Use
11.1. Cardiovascular Digital Solutions Market, by End-Use, 2024-2034
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Ambulatory Care Centers
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Cardiovascular Digital Solutions Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Components (2021-2034)
12.1.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Components (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Components (2021-2034)
12.2.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Components (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Components (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Components (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Components (2021-2034)
12.3.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Components (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Components (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Components (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Components (2021-2034)
12.4.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Components (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Components (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Components (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Components (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Service Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Components (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
Chapter 13. Company Profiles
13.1. iRythm Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Apple Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GENERAL ELECTRIC COMPANY
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Uber Diagnostics
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. AlivCor, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Verily Life Sciences LLC
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. HeartFlow, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bardy Diagnostics, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Bio Telemetry, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Koninkelijke Philips N.V.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample